EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

160 hedge funds and large institutions have $655M invested in Emergent Biosolutions in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 76 increasing their positions, 52 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
-8
Holders Change %
-4.76%
% of All Funds
4.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
76
Reduced
52
Closed
25
Calls
$7K
Puts
$45K
Net Calls
-$38K
Net Calls Change
-$357K

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$13.2M
2
PI
2
Putnam Investments
Massachusetts
$12M
3
BC
3
Broadfin Capital
New York
$46.7M
4
GC
4
Guggenheim Capital
Illinois
$8.23M
5
KCM
5
Kingdon Capital Management
New York
$9.14M

Top Sellers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$0
2
UBS AM
2
UBS AM
Illinois
$8.13M
3
BIM
3
Bogle Investment Management
Massachusetts
$0
4
Prudential Financial
4
Prudential Financial
New Jersey
$2.44M
5
CM
5
Castleark Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WMSA
176
Weiss Multi-Strategy Advisers
New York
– -$229K -9,050 Closed
PCM
177
Piermont Capital Management
Missouri
– -$215K -8,500 Closed
QBFM
178
QS Batterymarch Financial Management
New York
– -$210K -8,300 Closed
PC
179
Passport Capital
California
– -$202K -7,987 Closed
FNYS
180
First New York Securities
New York
– -$126K -5,000 Closed
KBC Group
181
KBC Group
Belgium
– -$55K -2,180 Closed
U
182
UBS
Switzerland
– -$39K -1,564 Closed
TRCT
183
Tower Research Capital (TRC)
New York
– -$2K -86 Closed
EFSCE
184
Enterprise Financial Services Corp (EFSC)
Missouri
– -$2K -60 Closed
4 5 6 7
8